Dr. Faith Davies is a professor of medicine and the director of the Phase I Clinical Trials program for both the Myeloma Institute and the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences. She is recognized internationally for her focus on innovative targeted molecular therapies and her expertise in the treatment of relapsed refractory myeloma. She is widely published in leading peer-reviewed journals and has contributed to a number of book chapters and reviews on myeloma biology and treatment.

http://www.hematology.org/Meetings/Malignancies/Speakers/3895.aspx